These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 27477825)

  • 21. Chronic myeloid leukemia: cytogenetic methods and applications for diagnosis and treatment.
    Morris CM
    Methods Mol Biol; 2011; 730():33-61. PubMed ID: 21431633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unusual Ph translocations in the French prospective study on chronic myeloid leukemia. Groupe Français de Cytogénétique Hématologique.
    Cancer Genet Cytogenet; 1985 Apr; 16(4):305-9. PubMed ID: 3856470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytogenetics of chronic myeloid leukaemia.
    Chase A; Huntly BJ; Cross NC
    Best Pract Res Clin Haematol; 2001 Sep; 14(3):553-71. PubMed ID: 11640869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Limited clinical value of regular bone marrow cytogenetic analysis in imatinib-treated chronic phase CML patients monitored by RQ-PCR for BCR-ABL.
    Ross DM; Branford S; Moore S; Hughes TP
    Leukemia; 2006 Apr; 20(4):664-70. PubMed ID: 16482210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Presence of Additional Cytogenetic Abnormality of t(1;15) at Diagnosis of Chronic Myelogenous Leukemia-Chronic Phase.
    Ji M; Hur M; Kim HN; Moon HW; Yun YM; Kim SY; Han SH
    Ann Clin Lab Sci; 2016 May; 46(3):308-11. PubMed ID: 27312558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular and cytogenetic characterization of a novel translocation t(4;22) involving the breakpoint cluster region and platelet-derived growth factor receptor-alpha genes in a patient with atypical chronic myeloid leukemia.
    Safley AM; Sebastian S; Collins TS; Tirado CA; Stenzel TT; Gong JZ; Goodman BK
    Genes Chromosomes Cancer; 2004 May; 40(1):44-50. PubMed ID: 15034867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recurrent Cytogenetic Abnormalities in Myeloproliferative Neoplasms and Chronic Myeloid Leukemia.
    Swansbury J
    Methods Mol Biol; 2017; 1541():247-256. PubMed ID: 27910028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The 5th edition of the WHO classification of haematolymphoid tumors: comments from the Groupe Francophone de Cytogénétique Hématologique (GFCH).
    Nguyen-Khac F; Bidet A; Troadec MB; Veronese L; Auger N; Daudignon A; Nadal N; Penther D; Michaux L; Lafage-Pochitaloff M; Lefebvre C
    Leukemia; 2023 Apr; 37(4):946-947. PubMed ID: 36707618
    [No Abstract]   [Full Text] [Related]  

  • 29. NUP98 rearrangements in hematopoietic malignancies: a study of the Groupe Francophone de Cytogénétique Hématologique.
    Romana SP; Radford-Weiss I; Ben Abdelali R; Schluth C; Petit A; Dastugue N; Talmant P; Bilhou-Nabera C; Mugneret F; Lafage-Pochitaloff M; Mozziconacci MJ; Andrieu J; Lai JL; Terre C; Rack K; Cornillet-Lefebvre P; Luquet I; Nadal N; Nguyen-Khac F; Perot C; Van den Akker J; Fert-Ferrer S; Cabrol C; Charrin C; Tigaud I; Poirel H; Vekemans M; Bernard OA; Berger R;
    Leukemia; 2006 Apr; 20(4):696-706. PubMed ID: 16467868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Response to the Comments from the Groupe Francophone de Cytogénétique Hématologique (GFCH) on the 5th edition of the World Health Organization classification of haematolymphoid tumors.
    Siebert R; Schuh A; Ott G; Cree IA; Du MQ; Ferry J; Hochhaus A; Naresh KN; Solary E; Khoury JD
    Leukemia; 2023 May; 37(5):1170-1172. PubMed ID: 36973349
    [No Abstract]   [Full Text] [Related]  

  • 31. Cytogenetics in the management of mature T-cell and NK-cell neoplasms: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH).
    Gaillard JB; Chapiro E; Daudignon A; Nadal N; Penther D; Chauzeix J; Nguyen-Khac F; Veronese L; Lefebvre C
    Curr Res Transl Med; 2023; 71(4):103428. PubMed ID: 38016421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. t(5;14)/HOX11L2-positive T-cell acute lymphoblastic leukemia. A collaborative study of the Groupe Français de Cytogénétique Hématologique (GFCH).
    Berger R; Dastugue N; Busson M; Van Den Akker J; Pérot C; Ballerini P; Hagemeijer A; Michaux L; Charrin C; Pages MP; Mugneret F; Andrieux J; Talmant P; Hélias C; Mauvieux L; Lafage-Pochitaloff M; Mozziconacci MJ; Cornillet-Lefebvre P; Radford I; Asnafi V; Bilhou-Nabera C; Nguyen Khac F; Léonard C; Speleman F; Poppe B; Bastard C; Taviaux S; Quilichini B; Herens C; Grégoire MJ; Cavé H; Bernard OA;
    Leukemia; 2003 Sep; 17(9):1851-7. PubMed ID: 12970786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Persistent clonal chromosomal abnormalities in a chronic myeloid leukemia patient.
    Muraoka M; Washio K; Kanamitu K; Kanazawa Y; Ishida T; Miyamura T; Chayama K; Nishiuchi R; Oda M; Shimada A
    Pediatr Int; 2016 Jan; 58(1):53-6. PubMed ID: 26542480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic role of conventional cytogenetics and fluorescence in situ hybridization (FISH) in chronic myeloid leukemia patients.
    Jha CB; Kucheria K; Choudhary VP
    Kathmandu Univ Med J (KUMJ); 2006; 4(2):171-5. PubMed ID: 18603893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Chronic myeloid leukemia--update].
    Tobler A; Solenthaler M
    Ther Umsch; 2004 Feb; 61(2):143-50. PubMed ID: 15018397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blast count and cytogenetics correlate and are useful parameters for the evaluation of different phases in chronic myeloid leukemia.
    Bacher U; Kern W; Schnittger S; Hiddemann W; Schoch C; Haferlach T
    Leuk Lymphoma; 2005 Mar; 46(3):357-66. PubMed ID: 15621825
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Impact of Cytogenetic Aberrations in the Clonal Evolution of Chronic Myeloid Leukemia: A Single-Center Experience Among 450 Turkish Patients (Cohort Study).
    Işık S; Günden G; Üsküdar Teke H; Akay OM; Oğuz Davutoğlu N; Aslan V; Karagülle M; Özen H; Çilingir O; Artan S; Durak Aras B
    Turk J Haematol; 2022 Dec; 39(4):237-244. PubMed ID: 36199265
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complex cytogenetic abnormalities in chronic myeloid leukemia resulting in early progression to blast crisis: a case report.
    Malakzai HA; Rahmani S; Haidary AM; Noor S; Ahmad M; Ibrahimkhil AS; Sharif S
    J Med Case Rep; 2020 Nov; 14(1):231. PubMed ID: 33243265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transient presence of clonal chromosomal aberrations in Ph-negative cells in patients with chronic myeloid leukemia remaining in deep molecular response on tyrosine kinase inhibitor treatment.
    Gniot M; Lewandowski K; Ratajczak B; Lewandowska M; Lehmann-Kopydłowska A; Jarmuż-Szymczak M; Komarnicki M
    Cancer Genet; 2014; 207(10-12):503-10. PubMed ID: 25496750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Omitting cytogenetic assessment from routine treatment response monitoring in chronic myeloid leukemia is safe.
    Geelen IGP; Thielen N; Janssen JJWM; Hoogendoorn M; Roosma TJA; Valk PJM; Visser O; Cornelissen JJ; Westerweel PE
    Eur J Haematol; 2018 Apr; 100(4):367-371. PubMed ID: 29288559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.